Schuelke MR, Bassiri H, Behrens EM, et al. Emapalumab for the treatment of refractory cytokine release syndrome in pediatric patients. Blood Adv. 2023;7(18):5603–5607.

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679801/
https://www.ncbi.nlm.nih.gov/pubmed/37966846
http://dx.doi.org/10.1182/bloodadvances.2023011828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679801/
https://www.ncbi.nlm.nih.gov/pubmed/37966846
http://dx.doi.org/10.1182/bloodadvances.2023011828

Ejemplares similares